Pinnacle Financial Group, Inc.’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$62.5K Buy
+7,500
New +$70.6K 0.01% 867

Other funds holding BCRX

Pinnacle Financial Group, Inc.'s BCRX Position: Q3 2026 in Review

Pinnacle Financial Group, Inc. opened a new position in BioCryst Pharmaceuticals (BCRX) in Q3 2026: 7,500 shares worth $62.5K. The stake represents 0.01% of the portfolio and ranks #867 among its holdings.

332 funds tracked by Wall St. Rank hold BCRX as of Q3 2026.

  • Pinnacle Financial Group, Inc. held 7,500 shares of BioCryst Pharmaceuticals worth $62.5K as of Q3 2026.
  • BioCryst Pharmaceuticals was a new Pinnacle Financial Group, Inc. position in Q3 2026.
  • BioCryst Pharmaceuticals made up 0.01% of Pinnacle Financial Group, Inc.'s portfolio in Q3 2026, its #867 holding.
  • 332 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q3 2026.

Based on Pinnacle Financial Group, Inc.'s 13F filing for Q3 2026, filed 16 Nov 2026.